[go: up one dir, main page]

WO1997039632A1 - Natural antioxidant composition - Google Patents

Natural antioxidant composition Download PDF

Info

Publication number
WO1997039632A1
WO1997039632A1 PCT/US1997/006821 US9706821W WO9739632A1 WO 1997039632 A1 WO1997039632 A1 WO 1997039632A1 US 9706821 W US9706821 W US 9706821W WO 9739632 A1 WO9739632 A1 WO 9739632A1
Authority
WO
WIPO (PCT)
Prior art keywords
grape seeds
composition
antioxidant
freezer
lyophilized
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US1997/006821
Other languages
French (fr)
Inventor
Harald P. Wulff
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Henkel Corp
Original Assignee
Henkel Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henkel Corp filed Critical Henkel Corp
Priority to AU27411/97A priority Critical patent/AU2741197A/en
Priority to EP97921349A priority patent/EP0897264A4/en
Publication of WO1997039632A1 publication Critical patent/WO1997039632A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23BPRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES
    • A23B2/00Preservation of foods or foodstuffs, in general
    • A23B2/70Preservation of foods or foodstuffs, in general by treatment with chemicals
    • A23B2/725Preservation of foods or foodstuffs, in general by treatment with chemicals in the form of liquids or solids
    • A23B2/729Organic compounds; Microorganisms; Enzymes
    • A23B2/733Compounds of undetermined constitution obtained from animals or plants
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23BPRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES
    • A23B2/00Preservation of foods or foodstuffs, in general
    • A23B2/90Preservation of foods or foodstuffs, in general by drying or kilning; Subsequent reconstitution
    • A23B2/92Freeze drying
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/87Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52Stabilizers
    • A61K2800/522Antioxidants; Radical scavengers

Definitions

  • This invention provides a composition comprising pulverized, lyophilized grape seeds, having beneficial antioxidant properties.
  • This composition may be
  • compositions which may be administered orally or topically to humans and animals, to provide protection from the harmful effects of free radicals in the human or animal body.
  • This composition also may be used as a natural food additive to prevent the oxidation of food products during
  • the present invention also provides a stable, natural source of proanthocyanodin antioxidant compounds which may be extracted by conventional means to provide a stable, highly purified, high potency antioxidant composition.
  • antioxidants are capable of protecting healthy cells from free radical damage.
  • Free radicals are unstable chemicals formed in the body during metabolism and from exposure to environmental sources, such as air pollution, cigarette smoke, and dietary fats. When there is an excessive number of free radicals in the body, they can attack healthy cells and can contribute to a number of degenerative diseases, such as cancer. The following is a list of diseases and conditions to which free radicals have been linked: Conditions Involving Multiple Organs
  • Senile dementia Contact dermatitis Parkinson disease - MPTP Photosensitive dyes Hypertensive cerebrovascular injury; Bloom syndrome cerebral trauma Allergic encephalomyelitis and other demyelinating diseases Ataxia-telangiectasia syndrome Potentiation of traumatic injury Aluminum overload Abetalipoproteinemia
  • Antioxidants quench free radicals before they have a chance to attack healthy cells. Antioxidants have been shown in the majority of studies to lower the risk for certain cancers, such as lung, stomach, cervix, breast, bladder, and
  • oral cancers Other health benefits include protection against heart diseases, cataracts, and age-related macular degeneration. While free radicals can cause or complicate many diseases, including cancer, arthritis, cataracts, and heart disease, antioxidants can help protect the body from these chronic disorders. They also enhance the body's immune system.
  • Typical antioxidant compounds used in pharmaceutical compositions include vitamin A and other carotenoid compounds, vitamin E and other tocopherols, and proanthocyanodins and their derivatives. These compounds may be produced synthetically (e.g. , by the method of U.S. Patent 2,917,539 (beta-
  • Proanthocyanodins are also nonteratogenic, nonmutagenic, and nonantigenic (thus providing for a very low risk of allergic reaction upon therapeutic administration), and have high
  • Antioxidants are also useful in the preservation of food, cosmetic, and pharmaceutical products.
  • Common antioxidants used in food, cosmetic, and pharmaceutical processing include sulfites, such as sodium bisulfite (a mixture of monosodium sulfite, NaHSO 3 , and sodium metabisulfite, Na 2 S 2 O 5 ), sodium metabisulfite, potassium metabisulfite (K 2 S : O 5 ), sulfur dioxide, and acids such as ascorbic and benzoic acid.
  • acids are unsuitable for use in many food, cosmetic, and pharmaceutical formulations.
  • exposure to sulfites, which are commonly used as antioxidants in the processing of many food products, including wine can produce acute airway obstruction and respiratory distress in sensitive individuals, particularly those suffering from asthma.
  • the present invention provides a natural antioxidant composition
  • a natural antioxidant composition comprising pulverized, lyophilized grape seeds. Grape seeds provide a natural source of antioxidant proanthocyanodins.
  • the composition of the present invention is thus a completely namral antioxidant which may readily be formulated into oral and topical pharmaceutical products for administration to humans or animals to provide protection from the harmful effects of free
  • the antioxidant composition of the present invention may also be used as a natural additive in food, cosmetic, or pharmaceutical products to prevent or retard their oxidation and spoilage.
  • the present invention also provides a stable, natural source of antioxidant
  • proanthocyanodins which may be extracted by conventional means to provide a stable, highly purified, high potency antioxidant proanthocyanodin composition for use in any application for which antioxidants are suitable.
  • the present invention provides a composition with beneficial antioxidant properties, comprising pulverized, lyophilized grape seeds.
  • a composition may be formulated as a stable, completely natural product.
  • the pulverized, lyophilized grape seeds which comprise the antioxidant composition of the present invention provide a natural source of antioxidant proanthocyanodins.
  • Proanthocyanodins form a class of natural polyphenols, defined by an exclusive property, namely the production of a red pigment (anthocyanodin) by the Bate-Smith reaction (Bate-Smith, E.C , and Swain, T. (1953) Chemistry & Industry pp 377-378).
  • Natural proanthocyanodins are typically an oligomeric mixture of proanthocyanodins having the general formula:
  • grape seeds may be ground or pulverized into a fine powder using any suitable method.
  • the whole or pulverized grape seeds are then lyophilized (freeze-dried) in order to remove at least 99%, and preferably more than 99% , of the water naturally contained in the grape seeds.
  • Lyophilization is a process of drying in which water is sublimed from the product after it is frozen. This serves to enhance their stability and shelf life, while maintaining the status of the grape seeds as a completely natural product. Lyophilization may be carried out using any means known in the art. Lyophilization essentially comprises freezing the product (in this case, pulverized grape seeds), evacuating the air from the freezer such that the air pressure falls usually below 0.1 torr (ice sublimes at pressures below 3 torr), subliming ice in the freezer on a cold condensing surface at a temperature below that of the product, and introducing heat to the product under controlled conditions, thus providing energy for sublimation of the ice in the product while maintaining the product below its eutectic temperature.
  • freezing the product in this case, pulverized grape seeds
  • evacuating the air from the freezer such that the air pressure falls usually below 0.1 torr (ice sublimes at pressures below 3 torr)
  • the grape seeds of the present invention may be used directly in any application in which a completely natural antioxidant is desired.
  • the pulverized, lyophilized grape seeds of the present invention are subject to conventional chemical extraction procedures in order to extract the antioxidant proanthocyanodins contained therein. This provides a stable, highly purified, high potency antioxidant proanthocyanodin composition for use in any application for which antioxidants are suitable. Proanthocyanodins may be extracted from
  • grapeseeds by any method known in the art, for example, by the method of U.S.
  • Patents 3,436,407 and 4,698,360 are disclosed.
  • proanthocyanodins are extracted from grape seeds by the following steps: grape seeds are first pulverized and extracted with boiling water (the extracted grape seeds can then be compressed or pressed to physically remove all liquid possible). The liquid is cooled to 20 ° C and filtered. Sodium chloride is added to saturation, and the precipitate formed is separated. The filtrate is extracted 3X with ethyl acetate at the rate of 1/10 the volume of
  • the ethyl acetate collected is dried on anhydrous Na 2 SO 4 and brought back to 1/5 of its volume by distillation under reduced pressure. It is then poured into three volumes of chloroform, while stirring mechanically.
  • the proanthocyanodins precipitate out, and may be collected by filtration. They may be further purified by redissolution in ethyl acetate and reprecipitation in chloroform. They may be finally washed with chloroform and dried at reduced pressure at a temperature no higher than 50 ° C.
  • the grape seeds are lyophilized first; in this form they may be stored for long periods prior to pulverizing and/or extraction of proanthocyanodins.
  • the lyophilized grape seeds may be pulverized while in the lyophilized state; alternatively, the grape seeds may be reconstituted prior to pulverizing.
  • the present invention also provides an oral antioxidant pharmaceutical composition.
  • a composition may comprise the pulverized, lyophilized grapeseeds according to the present invention, where a completely natural
  • the composition may comprise purified proanthocyanodins extracted from pulverized, lyophilized grapeseeds, where a more purified antioxidant composition is desired.
  • the oral antioxidant pharmaceutical composition according to the present invention will be described in detail below.
  • a pharmaceutically acceptable carrier suitable for oral administration.
  • compositions of the present invention can be made by conventional compounding procedures known in the pharmaceutical art, that is, by mixing the active substances with edible pharmaceutically acceptable non-toxic inert, solid or liquid carriers and/or excipients suitable for systemic administration and conventionally used in oral dosage forms.
  • carriers for use in the present invention will be natural carriers, such as edible oils.
  • edible oil may be a vegetable oil such as avocado, coconut, corn, grape seed, palm, peanut, olive, sesame, soya, rapeseed, or walnut oil or any other edible vegetable oil or mixture of one or more of these oils. Additionally, edible, non- toxic pharmaceutically acceptable stabilizers usually used as stabilizers in oral dosage forms or edible, non-toxic salts thereof can be included in the
  • the stabilizer will be beeswax or silica. All the above carriers, excipients and stabilizers are intended to include only those suitable for oral administration and all are conventional and known to the pharmaceutical art.
  • the pharmaceutical compositions for oral administration may be in the
  • the patient ingests the composition preferably daily to obtain the benefit of the administration of the proanthocyanodins.
  • the dosage of the antioxidant composition of the present invention administered to a patient will vary depending upon several factors, including, but not limited to, the age and weight of the patient, the general health of the patient, the severity of the symptoms, and the like.
  • the present invention also provides topical antioxidant pharmaceutical compositions, and cosmetic compositions containing antioxidants. Such a
  • composition may comprise the pulverized, lyophilized grapeseeds according to the present invention, where a completely natural product is desired.
  • composition may comprise purified proanthocyanodins extracted from pulverized, lyophilized grapeseeds, where a more purified antioxidant composition is desired.
  • the topical antioxidant may comprise the pulverized, lyophilized grapeseeds according to the present invention, where a completely natural product is desired.
  • the composition may comprise purified proanthocyanodins extracted from pulverized, lyophilized grapeseeds, where a more purified antioxidant composition is desired.
  • the topical antioxidant may comprise the pulverized, lyophilized grapeseeds according to the present invention, where a completely natural product is desired.
  • the topical antioxidant may comprise the topical antioxidant
  • compositions or cosmetic composition according to the present invention will further comprise a carrier suitable for topical administration.
  • the pulverized lyophilized grape seeds which comprise the natural antioxidant
  • composition of the present invention may be used in all galenical forms normally used for topical application, in particular lotion or serum-type solutions or dispersions, liquid or semi-liquid milk emulsions produced by dispersions of a fatty phase in an aqueous phase (O/W) or the reverse (W/O), or cream- or gel- type emulsions having a soft consistency, or microgranulates or vesicular ionic and/or non- ionic dispersions.
  • lotion or serum-type solutions or dispersions liquid or semi-liquid milk emulsions produced by dispersions of a fatty phase in an aqueous phase (O/W) or the reverse (W/O)
  • cream- or gel- type emulsions having a soft consistency or microgranulates or vesicular ionic and/or non- ionic dispersions.
  • the natural antioxidant composition of the present invention may be added to a wide variety of products for topical application, including makeup, creams for cleansing, protecting, treating, or caring for the skin, in particular, the face, hands, and feet (e.g. , day and night creams, makeup removal creams, foundation creams and sunscreens), liquid foundations, makeup removal lotions, protective or skin-care body lotions, sunscreen lotions, skin care lotions, gels, or foams, such as cleansing, sunscreen, and artificial tanning lotions, bath preparations, deodorant compositions, after-shave gels or lotions, depilatory creams, and compositions used for insect stings and against pain.
  • the topical compositions according to the invention may also consist of solid preparations used for soaps and cleansing bars.
  • topical compositions according to the present invention may also contain additives customarily used in cosmetics, such as
  • water-absorbent or lipophilic gelling agents water-absorbent or lipophilic active ingredients, preservatives, solvents, perfumes, fillers, screens, and coloring substances.
  • the quantities of these various additives are those conventionally used in cosmetics; for example, from 0.1 % to 10% of the total weight of the
  • additives may, depending on the nature thereof, be added to the fatty phase, the aqueous phase, and/or in lipidic spherules.
  • lipidic spherules Preferably, such additives are natural substances.
  • Oils suitable for use in the topical compositions of the present invention include mineral oils (e.g. , vaseline oil), vegetable oils (e.g., sunflower oil), animal oils (e.g., perhydrosqualene), synthetic oils (e.g., Purcellin oil), silicone containing oils, (e.g. , cyclomethicone) and fluorinated oils (e.g. , perfluoropolyethers).
  • mineral oils e.g. , vaseline oil
  • vegetable oils e.g., sunflower oil
  • animal oils e.g., perhydrosqualene
  • synthetic oils e.g., Purcellin oil
  • silicone containing oils e.g. , cyclomethicone
  • fluorinated oils e.g. , perfluoropolyethers.
  • Fatty alcohols and fatty acids e.g. , stearic acid
  • the oil is a natural vegetable oil.
  • Emulsifiers suitable for use in the topical compositions of the present invention include, for example, glycerol stearate, polysorbate 60, and a PEG-6/PEG-32/glycol stearate mixture (Tefose ® ).
  • Solvents suitable for use in the topical compositions of the present invention include, for example, the lower alcohols, in particular ethanol and
  • carboxyvinyl polymers include carboxyvinyl polymers, acrylic copolymers (e.g. , acrylate/alkylacrylate copolymers), poly aery lamides, polysaccharides (e.g. , hydroxypropylcellulose), and, preferably, natural gums and clays.
  • Lipophilic gelling agents suitable for use in the topical compositions of the present invention include carboxyvinyl polymers, acrylic copolymers (e.g. , acrylate/alkylacrylate copolymers), poly aery lamides, polysaccharides (e.g. , hydroxypropylcellulose), and, preferably, natural gums and clays.
  • Lipophilic gelling agents suitable for use in the topical compositions of the present invention include carboxyvinyl polymers, acrylic copolymers (e.g. , acrylate/alkylacrylate copolymers), poly aery lamides, polysaccharides (e.g. , hydroxy
  • modified clays e.g., bentonites
  • the metallic salts of fatty acids e.g. , aluminum stearates
  • hydrophobic silica e.g., silica
  • Water-absorbing active ingredients include proteins and protein hydrolysates, amino acids, polyalcohols, urea, allantoin, sugars and sugar
  • Lipophilic active ingredients include retinol (vitamin A) and derivatives thereof, tocopherol (vitamin E) and derivatives thereof, essential fatty acids,
  • ceramides ceramides, essential oils, and salicylic acid and derivatives thereof.
  • the pulverized, lyophilized grape seeds of the present invention may also be combined with active ingredients intended, in particular, for the prevention and/or treatment of skin disorders.
  • active ingredients may include, for example:
  • agents modulating the differentiation, proliferation, and/or skin pigmentation such as retinoic acid and isomers thereof, retinol and esters thereof, vitamin D and derivatives thereof, estrogens such as estradiol, kojik acid and hydroquinone;
  • - antibacterial agents such as clindamycin phosphate, erythromycin, tetracycline antibiotics, and the like
  • - antifungal agents such as imidazoles (e.g. , econazole, ketoconazole,
  • miconazole and salts thereof, polyenes (e.g. , amphotericin B), allylamines (e.g. , terbinafine, octopirox), and the like;
  • polyenes e.g. , amphotericin B
  • allylamines e.g. , terbinafine, octopirox
  • - steroidal anti-inflammatory agents such as hydrocortisone, betamethasone valerate, clobetasol propionate, and the like, or nonsteroidal anti- inflammatory agents, such as ibuprofen, ketoprofen, and salts thereof, diclofenac
  • - anesthetic agents such as lidocaine chlorhydrate and derivatives thereof, and the like;
  • - anti-pruriginous agents such as thenaldine, trimeprazine, and cyproheptadine, and the like;
  • antiviral agents such as acyclovir, and the like
  • - keratolytic agents such as a- and ⁇ -hydroxycarboxylic and ⁇ - ketocarboxylic acids, and salts, amides, and esters thereof, hydroxy acids, such as glycolic, lactic, salicylic, and citric acid, and, in general, fruit acids, and the like;
  • antioxidants such as ⁇ -tocopherol and esters thereof, superoxide dismutases, metal chelating agents, ascorbic acid and esters thereof, and the like;
  • - anti-seborrhea agents such as progesterone, and the like;
  • the present invention also includes a method for quenching free radicals comprising administering to a mammal, including a human, in need of such treatment an antioxidant effective amount of an antioxidant composition according to the present invention.
  • a method for quenching free radicals comprising administering to a mammal, including a human, in need of such treatment an antioxidant effective amount of an antioxidant composition according to the present invention.
  • Such a method may comprise administering
  • the method may comprise administering an antioxidant effective amount of purified proanthocyanodins extracted from pulverized, lyophilized grapeseeds.
  • This method may be practiced by administration of an antioxidant composition according to the present invention by itself, or in combination with other active ingredients, including other antioxidants, and/or therapeutic agents in
  • Suitable for use herein are any compatible drugs that are effective by the same or other mechanisms for the intended purpose, or drugs that are complementary to those of the present agents.
  • Examples include carotenoids (e.g. , beta carotene derived from Dunaliella salina) and vitamins (e.g. , natural tocopherols derived from soybean oil, such as d- ⁇ -tocopherol), among others.
  • the compatible compounds will preferably be natural antioxidants.
  • the compounds utilized in combination therapy may be administered simultaneously, in either separate or combined formulations, or at different times than the compositions according to the present invention, e.g. , sequentially, such that a combined effect is achieved.
  • the amounts and regime of administration will be adjusted by the practitioner, by preferably initially lowering their standard doses and then titrating the results obtained.
  • Antioxidant food additive The present invention also provides an antioxidant composition which may be added to food products to prevent oxidation.
  • a composition may comprise the pulverized, lyophilized grapeseeds according to the present invention, where a completely natural product is desired.
  • the composition may comprise purified proanthocyanodins extracted from pulverized, lyophilized grapeseeds, where a more purified antioxidant composition is desired.
  • the antioxidant composition of the present invention is suitable for addition to wine, in order to prevent oxidation of the wine. In the typical fermentation process, wines may be dosed with the antioxidant composition of the present invention at any time during fermentation.
  • wines are dosed with the antioxidant composition of the present invention at the time of bottling, as a substitute for all or part of the sulfur dioxide typically used to prevent oxidation in winemaking.
  • the present invention also provides a process for preventin the oxidation of food products comprising adding to a food product an antioxidant effective amount of an antioxidant composition according to the present invention during the preparation or processing of the food product. While the invention has been described and illustrated herein by

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Botany (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)

Abstract

The present invention provides a composition comprising pulverized, lyophilized grape seeds. This natural antioxidant composition may readily be formulated into oral and topical pharmaceutical products for administration to humans or animals to provide protection from the harmful effects of free radicals. The natural antioxidant composition of the present invention may also be used as a natural additive in food, cosmetic, or pharmaceutical products to prevent or retard their oxidation and spoilage. The present invention also provides a stable, natural source of proanthocyanodin antioxidant compounds which may be extracted by conventional means to provide a stable, more highly purified antioxidant composition.

Description

NATURAL ANTIOXIDANT COMPOSITION
BACKGROUND OF THE INVENTION
FIELD OF THE INVENTION
This invention provides a composition comprising pulverized, lyophilized grape seeds, having beneficial antioxidant properties. This composition may be
used in pharmaceutical compositions which may be administered orally or topically to humans and animals, to provide protection from the harmful effects of free radicals in the human or animal body. This composition also may be used as a natural food additive to prevent the oxidation of food products during
processing. The present invention also provides a stable, natural source of proanthocyanodin antioxidant compounds which may be extracted by conventional means to provide a stable, highly purified, high potency antioxidant composition.
BACKGROUND Recent scientific studies have provided evidence that antioxidants are capable of protecting healthy cells from free radical damage. Free radicals are unstable chemicals formed in the body during metabolism and from exposure to environmental sources, such as air pollution, cigarette smoke, and dietary fats. When there is an excessive number of free radicals in the body, they can attack healthy cells and can contribute to a number of degenerative diseases, such as cancer. The following is a list of diseases and conditions to which free radicals have been linked: Conditions Involving Multiple Organs
Inflammatory-immune injury Nutritional deficiencies Glomerulonephritis Kwashiorkor
(idiopathic, membranous) Vitamin E deficiency Vasculitis (hepatitis B virus, drugs) Autoimmune diseases Alcohol damage
Ischemia-reflow states Radiation injury
Drug and toxin-induced reactions Aging
Disorders of "premature aging"
Iron overload Immune deficiency of age
Idiopathic hemochromatosis Dietary iron overload Cancer Thalassemia and other chronic anemias Amyloid diseases
Conditions Involving Single Organs
Erythrocytes Joint abnormalities
Phenylhydrazine Rheumatoid arthritis
Primaquine
Lead poisoning Heart and cardiovascular
Protoporphyrin photo-oxidation Alcohol cardiomyopathy Malaria Keshan diseases (selenium
Sickle-cell anemia deficiency)
Favism Atherosclerosis
Fanconi anemia Doxorubicin toxicity
Lung Kidney Cigarette-smoke effects Nephrotic antiglomerular basement
Emphysema membrane disease
Hyperoxia Aminoglycoside nephrotoxicity
Bronchopulmonary dysplasia Heavy metal nephrotoxicity
Oxidant pollutants Renal graft rejection Acute respiratory distress syndrome
Mineral dust pneumoconiosis
Bleomycin toxicity
Paraquat toxicity Gastrointestinal tract Eye Endotoxin liver injury Cataractogenesis Carbon tetrachloride liver injury Ocular hemorrhage Diabetogenic action of alloxan Degenerative retinal damage Free fatty acid-induced pancreatitis Retinopathy of prematurity Nonsteroidal anti- inflammatory drug- Photic retinopathy induced lesions
Skin
Brain Solar radiation
Hyperbaric oxygen Thermal injury Neurotoxins Porphyria
Senile dementia Contact dermatitis Parkinson disease - MPTP Photosensitive dyes Hypertensive cerebrovascular injury; Bloom syndrome cerebral trauma Allergic encephalomyelitis and other demyelinating diseases Ataxia-telangiectasia syndrome Potentiation of traumatic injury Aluminum overload Abetalipoproteinemia
Antioxidants quench free radicals before they have a chance to attack healthy cells. Antioxidants have been shown in the majority of studies to lower the risk for certain cancers, such as lung, stomach, cervix, breast, bladder, and
oral cancers. Other health benefits include protection against heart diseases, cataracts, and age-related macular degeneration. While free radicals can cause or complicate many diseases, including cancer, arthritis, cataracts, and heart disease, antioxidants can help protect the body from these chronic disorders. They also enhance the body's immune system.
Typical antioxidant compounds used in pharmaceutical compositions include vitamin A and other carotenoid compounds, vitamin E and other tocopherols, and proanthocyanodins and their derivatives. These compounds may be produced synthetically (e.g. , by the method of U.S. Patent 2,917,539 (beta-
carotene) and U.S. Patent 5,208,381 (lycopene)). Alternatively, these compounds may be extracted from plant matter using solvent-based extraction systems, such as the method of Karrer et al. (Helv. Chim. Acta 16:641 (1933) (extraction of alpha carotene or lutein); the method of U.S. Patent 4,698,360 (extraction of proanthocyanodins from pine bark); the method of U.S. Patent 2,848,508 (extraction of beta-carotene); and the method of German Patent 1 , 168,890 (extraction of lycopene). Proanthocyanodins are antioxidant pycnogenols. They are characterized among the plant polyphenols by their low toxicity (LD50 = 3g/kg), and corresponding low risk of acute or chronic intoxication upon therapeutic administration. Proanthocyanodins are also nonteratogenic, nonmutagenic, and nonantigenic (thus providing for a very low risk of allergic reaction upon therapeutic administration), and have high
bioavailability following oral administration. Antioxidants are also useful in the preservation of food, cosmetic, and pharmaceutical products. Common antioxidants used in food, cosmetic, and pharmaceutical processing include sulfites, such as sodium bisulfite (a mixture of monosodium sulfite, NaHSO3, and sodium metabisulfite, Na2S2O5), sodium metabisulfite, potassium metabisulfite (K2S:O5), sulfur dioxide, and acids such as ascorbic and benzoic acid. However, acids are unsuitable for use in many food, cosmetic, and pharmaceutical formulations. Furthermore, exposure to sulfites, which are commonly used as antioxidants in the processing of many food products, including wine, can produce acute airway obstruction and respiratory distress in sensitive individuals, particularly those suffering from asthma.
Concern for avoiding such reactions has prompted a decrease in the use of sulfiting agents as sanitizing and preservative agents in food products; however,
in many instances, no reliable substitute exists. In view of the aforementioned deficiencies attendant with prior art antioxidant compositions, it should be apparent that there still exists in the art a need for an improved, natural antioxidant composition. Such a composition
would be useful for its therapeutic benefits, and to prevent oxidation of pharmaceutical, cosmetic, and food compositions, without provoking the undesirable and sometimes dangerous side effects associated with prior art antioxidant compositions.
SUMMARY OF THE INVENTION
Accordingly, the present invention provides a natural antioxidant composition comprising pulverized, lyophilized grape seeds. Grape seeds provide a natural source of antioxidant proanthocyanodins. The composition of the present invention is thus a completely namral antioxidant which may readily be formulated into oral and topical pharmaceutical products for administration to humans or animals to provide protection from the harmful effects of free
radicals. The antioxidant composition of the present invention may also be used as a natural additive in food, cosmetic, or pharmaceutical products to prevent or retard their oxidation and spoilage. The present invention also provides a stable, natural source of antioxidant
proanthocyanodins which may be extracted by conventional means to provide a stable, highly purified, high potency antioxidant proanthocyanodin composition for use in any application for which antioxidants are suitable. With the foregoing and other objects, advantages and features of the
invention that will become hereinafter apparent, the nature of the invention may be more clearly understood by reference to the following detailed description of the preferred embodiments of the invention and to the appended claims.
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS OF THE INVENTION
Accordingly, the present invention provides a composition with beneficial antioxidant properties, comprising pulverized, lyophilized grape seeds. Such a composition may be formulated as a stable, completely natural product. The pulverized, lyophilized grape seeds which comprise the antioxidant composition of the present invention provide a natural source of antioxidant proanthocyanodins. Proanthocyanodins form a class of natural polyphenols, defined by an exclusive property, namely the production of a red pigment (anthocyanodin) by the Bate-Smith reaction (Bate-Smith, E.C , and Swain, T. (1953) Chemistry & Industry pp 377-378). Natural proanthocyanodins are typically an oligomeric mixture of proanthocyanodins having the general formula:
Figure imgf000009_0001
where rings A and/or B are substituted with one or more hydroxy groups. In the practice of the present invention, grape seeds may be ground or pulverized into a fine powder using any suitable method. The whole or pulverized grape seeds are then lyophilized (freeze-dried) in order to remove at least 99%, and preferably more than 99% , of the water naturally contained in the grape seeds.
Lyophilization is a process of drying in which water is sublimed from the product after it is frozen. This serves to enhance their stability and shelf life, while maintaining the status of the grape seeds as a completely natural product. Lyophilization may be carried out using any means known in the art. Lyophilization essentially comprises freezing the product (in this case, pulverized grape seeds), evacuating the air from the freezer such that the air pressure falls usually below 0.1 torr (ice sublimes at pressures below 3 torr), subliming ice in the freezer on a cold condensing surface at a temperature below that of the product, and introducing heat to the product under controlled conditions, thus providing energy for sublimation of the ice in the product while maintaining the product below its eutectic temperature.
Once pulverized and lyophilized, the grape seeds of the present invention may be used directly in any application in which a completely natural antioxidant is desired. In another embodiment of the present invention, the pulverized, lyophilized grape seeds of the present invention are subject to conventional chemical extraction procedures in order to extract the antioxidant proanthocyanodins contained therein. This provides a stable, highly purified, high potency antioxidant proanthocyanodin composition for use in any application for which antioxidants are suitable. Proanthocyanodins may be extracted from
grapeseeds by any method known in the art, for example, by the method of U.S.
Patents 3,436,407 and 4,698,360.
In an exemplary method, proanthocyanodins are extracted from grape seeds by the following steps: grape seeds are first pulverized and extracted with boiling water (the extracted grape seeds can then be compressed or pressed to physically remove all liquid possible). The liquid is cooled to 20 °C and filtered. Sodium chloride is added to saturation, and the precipitate formed is separated. The filtrate is extracted 3X with ethyl acetate at the rate of 1/10 the volume of
the aqueous phase. The ethyl acetate collected is dried on anhydrous Na2SO4 and brought back to 1/5 of its volume by distillation under reduced pressure. It is then poured into three volumes of chloroform, while stirring mechanically. The proanthocyanodins precipitate out, and may be collected by filtration. They may be further purified by redissolution in ethyl acetate and reprecipitation in chloroform. They may be finally washed with chloroform and dried at reduced pressure at a temperature no higher than 50 °C.
In another embodiment of the present invention, the grape seeds are lyophilized first; in this form they may be stored for long periods prior to pulverizing and/or extraction of proanthocyanodins. The lyophilized grape seeds may be pulverized while in the lyophilized state; alternatively, the grape seeds may be reconstituted prior to pulverizing.
Oral antioxidant pharmaceutical compositions
The present invention also provides an oral antioxidant pharmaceutical composition. Such a composition may comprise the pulverized, lyophilized grapeseeds according to the present invention, where a completely natural
product is desired. Alternatively, the composition may comprise purified proanthocyanodins extracted from pulverized, lyophilized grapeseeds, where a more purified antioxidant composition is desired. In either case, the oral antioxidant pharmaceutical composition according to the present invention will
further comprise a pharmaceutically acceptable carrier suitable for oral administration.
The oral compositions of the present invention can be made by conventional compounding procedures known in the pharmaceutical art, that is, by mixing the active substances with edible pharmaceutically acceptable non-toxic inert, solid or liquid carriers and/or excipients suitable for systemic administration and conventionally used in oral dosage forms. Preferably, carriers for use in the present invention will be natural carriers, such as edible oils. The
edible oil may be a vegetable oil such as avocado, coconut, corn, grape seed, palm, peanut, olive, sesame, soya, rapeseed, or walnut oil or any other edible vegetable oil or mixture of one or more of these oils. Additionally, edible, non- toxic pharmaceutically acceptable stabilizers usually used as stabilizers in oral dosage forms or edible, non-toxic salts thereof can be included in the
compositions. Preferably, the stabilizer will be beeswax or silica. All the above carriers, excipients and stabilizers are intended to include only those suitable for oral administration and all are conventional and known to the pharmaceutical art. The pharmaceutical compositions for oral administration may be in the
form of tablets, including sustained release forms, lozenges, chewing gum, and capsules. The soft gelatin capsule dosage form is most preferred. These dosage forms may be prepared by those skilled in the art in accordance with known
techniques in the art, for example, as described in Remington 's Pharmaceutical Sciences, 17th Edition (1985), Mack Publishing Co. , Easton, PA.
According to the present invention, the patient ingests the composition preferably daily to obtain the benefit of the administration of the proanthocyanodins. The dosage of the antioxidant composition of the present invention administered to a patient will vary depending upon several factors, including, but not limited to, the age and weight of the patient, the general health of the patient, the severity of the symptoms, and the like.
Topical antioxidant pharmaceutical compositions, and cosmetic compositions containing antioxidants
The present invention also provides topical antioxidant pharmaceutical compositions, and cosmetic compositions containing antioxidants. Such a
composition may comprise the pulverized, lyophilized grapeseeds according to the present invention, where a completely natural product is desired. Alternatively, the composition may comprise purified proanthocyanodins extracted from pulverized, lyophilized grapeseeds, where a more purified antioxidant composition is desired. In either case, the topical antioxidant
pharmaceutical composition or cosmetic composition according to the present invention will further comprise a carrier suitable for topical administration.
For use in topical pharmaceutical and cosmetic compositions, the pulverized lyophilized grape seeds which comprise the natural antioxidant
composition of the present invention may be used in all galenical forms normally used for topical application, in particular lotion or serum-type solutions or dispersions, liquid or semi-liquid milk emulsions produced by dispersions of a fatty phase in an aqueous phase (O/W) or the reverse (W/O), or cream- or gel- type emulsions having a soft consistency, or microgranulates or vesicular ionic and/or non- ionic dispersions.
The natural antioxidant composition of the present invention may be added to a wide variety of products for topical application, including makeup, creams for cleansing, protecting, treating, or caring for the skin, in particular, the face, hands, and feet (e.g. , day and night creams, makeup removal creams, foundation creams and sunscreens), liquid foundations, makeup removal lotions, protective or skin-care body lotions, sunscreen lotions, skin care lotions, gels, or foams, such as cleansing, sunscreen, and artificial tanning lotions, bath preparations, deodorant compositions, after-shave gels or lotions, depilatory creams, and compositions used for insect stings and against pain. The topical compositions according to the invention may also consist of solid preparations used for soaps and cleansing bars.
In conventional fashion, the topical compositions according to the present invention may also contain additives customarily used in cosmetics, such as
water-absorbent or lipophilic gelling agents, water-absorbent or lipophilic active ingredients, preservatives, solvents, perfumes, fillers, screens, and coloring substances. The quantities of these various additives are those conventionally used in cosmetics; for example, from 0.1 % to 10% of the total weight of the
composition. These additives may, depending on the nature thereof, be added to the fatty phase, the aqueous phase, and/or in lipidic spherules. Preferably, such additives are natural substances.
Oils suitable for use in the topical compositions of the present invention include mineral oils (e.g. , vaseline oil), vegetable oils (e.g., sunflower oil), animal oils (e.g., perhydrosqualene), synthetic oils (e.g., Purcellin oil), silicone containing oils, (e.g. , cyclomethicone) and fluorinated oils (e.g. , perfluoropolyethers). Fatty alcohols and fatty acids (e.g. , stearic acid) can be
added to these oils. Preferably, the oil is a natural vegetable oil.
Emulsifiers suitable for use in the topical compositions of the present invention include, for example, glycerol stearate, polysorbate 60, and a PEG-6/PEG-32/glycol stearate mixture (Tefose®).
Solvents suitable for use in the topical compositions of the present invention include, for example, the lower alcohols, in particular ethanol and
isopropanol. Water-absorbent gelling agents suitable for use in the topical compositions
of the present invention include carboxyvinyl polymers, acrylic copolymers (e.g. , acrylate/alkylacrylate copolymers), poly aery lamides, polysaccharides (e.g. , hydroxypropylcellulose), and, preferably, natural gums and clays. Lipophilic gelling agents suitable for use in the topical compositions of the present invention
include modified clays (e.g., bentonites), the metallic salts of fatty acids (e.g. , aluminum stearates), and hydrophobic silica.
Water-absorbing active ingredients include proteins and protein hydrolysates, amino acids, polyalcohols, urea, allantoin, sugars and sugar
derivatives, vitamins, and hydroxy acids.
Lipophilic active ingredients include retinol (vitamin A) and derivatives thereof, tocopherol (vitamin E) and derivatives thereof, essential fatty acids,
ceramides, essential oils, and salicylic acid and derivatives thereof.
The pulverized, lyophilized grape seeds of the present invention may also be combined with active ingredients intended, in particular, for the prevention and/or treatment of skin disorders. Such active ingredients may include, for example:
- agents modulating the differentiation, proliferation, and/or skin pigmentation, such as retinoic acid and isomers thereof, retinol and esters thereof, vitamin D and derivatives thereof, estrogens such as estradiol, kojik acid and hydroquinone;
- antibacterial agents such as clindamycin phosphate, erythromycin, tetracycline antibiotics, and the like; - antifungal agents, such as imidazoles (e.g. , econazole, ketoconazole,
miconazole) and salts thereof, polyenes (e.g. , amphotericin B), allylamines (e.g. , terbinafine, octopirox), and the like;
- steroidal anti-inflammatory agents, such as hydrocortisone, betamethasone valerate, clobetasol propionate, and the like, or nonsteroidal anti- inflammatory agents, such as ibuprofen, ketoprofen, and salts thereof, diclofenac
and salts thereof, acetylsalicylic acid, acetaminophen, glycyrrhetinic acid, and the like;
- anesthetic agents, such as lidocaine chlorhydrate and derivatives thereof, and the like;
- anti-pruriginous agents, such as thenaldine, trimeprazine, and cyproheptadine, and the like;
- antiviral agents, such as acyclovir, and the like;
- keratolytic agents, such as a- and ^-hydroxycarboxylic and β- ketocarboxylic acids, and salts, amides, and esters thereof, hydroxy acids, such as glycolic, lactic, salicylic, and citric acid, and, in general, fruit acids, and the like;
- other antioxidants, such as α-tocopherol and esters thereof, superoxide dismutases, metal chelating agents, ascorbic acid and esters thereof, and the like; - anti-seborrhea agents, such as progesterone, and the like; and
- acne-fighting products, such as retinoic acid or benzoyl peroxide, and
the like. Method of treatment
The present invention also includes a method for quenching free radicals comprising administering to a mammal, including a human, in need of such treatment an antioxidant effective amount of an antioxidant composition according to the present invention. Such a method may comprise administering
an effective amount of pulverized, lyophilized grape seeds to quench free radicals. Alternatively, the method may comprise administering an antioxidant effective amount of purified proanthocyanodins extracted from pulverized, lyophilized grapeseeds. This method may be practiced by administration of an antioxidant composition according to the present invention by itself, or in combination with other active ingredients, including other antioxidants, and/or therapeutic agents in
a pharmaceutical composition. Other therapeutic agents suitable for use herein are any compatible drugs that are effective by the same or other mechanisms for the intended purpose, or drugs that are complementary to those of the present agents. Examples include carotenoids (e.g. , beta carotene derived from Dunaliella salina) and vitamins (e.g. , natural tocopherols derived from soybean oil, such as d-α-tocopherol), among others. In the case where a totally natural product is desired, the compatible compounds will preferably be natural antioxidants.
The compounds utilized in combination therapy may be administered simultaneously, in either separate or combined formulations, or at different times than the compositions according to the present invention, e.g. , sequentially, such that a combined effect is achieved. The amounts and regime of administration will be adjusted by the practitioner, by preferably initially lowering their standard doses and then titrating the results obtained.
Antioxidant food additive The present invention also provides an antioxidant composition which may be added to food products to prevent oxidation. Such a composition may comprise the pulverized, lyophilized grapeseeds according to the present invention, where a completely natural product is desired. Alternatively, the composition may comprise purified proanthocyanodins extracted from pulverized, lyophilized grapeseeds, where a more purified antioxidant composition is desired. In particular, the antioxidant composition of the present invention is suitable for addition to wine, in order to prevent oxidation of the wine. In the typical fermentation process, wines may be dosed with the antioxidant composition of the present invention at any time during fermentation. Preferably, wines are dosed with the antioxidant composition of the present invention at the time of bottling, as a substitute for all or part of the sulfur dioxide typically used to prevent oxidation in winemaking. The present invention also provides a process for preventin the oxidation of food products comprising adding to a food product an antioxidant effective amount of an antioxidant composition according to the present invention during the preparation or processing of the food product. While the invention has been described and illustrated herein by
references to various specific material, procedures and examples, it is understood that the invention is not restricted to the particular material, combinations of material, and procedures selected for that purpose. Numerous variations of such details can be implied and will be appreciated by those skilled in the art.

Claims

What is claimed is:
1. A composition comprising lyophilized grape seeds.
2. The composition of claim 1 wherein the grape seeds are pulverized prior to lyophilization.
3. The composition of claim 1 wherein the grape seeds are pulverized subsequent to lyophilization.
4. The composition of claim 1 , wherein the grape seeds are lyophilized by a process comprising the steps of: freezing the grape seeds in a freezer; reducing the air pressure in the freezer; subliming ice in the freezer on a cold condensing surface at a temperature below that of the grape seeds; and introducing heat to the grape seeds while maintaining them below their eutectic temperature.
5. The composition of claim 4, wherein the pressure in the freezer is reduced below 0.1 torr.
6. The composition of claim 5, wherein more than 99% of the water naturally occurring in the grape seeds is removed.
7. A process for producing lyophilized grape seeds comprising the steps of: freezing grape seeds in a freezer;
reducing the air pressure in the freezer; subliming ice in the freezer on a cold condensing surface at a temperature below that of the grape seeds; and introducing heat to the grape seeds while maintaining them below their
eutectic temperature.
8. The process of claim 7, wherein the pressure in the freezer is reduced below 0.1 torr.
9. The process of claim 7, wherein more than 99% of the water naturally occurring in the grape seeds is removed.
10. The process of claim 7, further comprising the step of pulverizing the grape seeds prior to lyophilization.
11. The process of claim 7, further comprising the step of pulverizing the grape seeds subsequent to lyophilization.
12. An antioxidant pharmaceutical composition comprising an effective
antioxidant amount of pulverized, lyophilized grape seeds and a pharmaceutically acceptable carrier therefor.
13. The antioxidant composition of claim 12 suitable for oral administration.
14. The antioxidant composition of claim 12 suitable for topical administration.
15. A cosmetic composition comprising an effective amount of the composition of pulverized, lyophilized grape seeds and a cosmetically acceptable carrier therefor.
16. A method of preventing or inhibiting the damaging effects of free radicals comprising administering to a mammal in need of such treatment an effective antioxidant amount of the composition of claim 1.
17. A composition for preventing or inhibiting the oxidation of food products comprising the composition of claim 1.
18. A process for preventing the oxidation of food products comprising adding to a food product an antioxidant effective amount of a natural antioxidant composition comprising the composition of claim 1 during the preparation or processing of the food product.
19. The process of claim 18, wherein the food product is wine.
20. The process of claim 18, wherein the wine is dosed with the antioxidant
composition at the time of bottling, as a substitute for all or part of the sulfur dioxide typically used to prevent oxidation in winemaking.
21. An antioxidant composition comprising an antioxidant effective amount of
proanthocyanodins extracted from pulverized, lyophilized grape seeds and a carrier therefor.
22. A method for producing purified proanthocyanodins comprising:
freezing grape seeds in a freezer; reducing the air pressure in the freezer; subliming ice in the freezer on a cold condensing surface at a temperature below that of the grape seeds; introducing heat to the grape seeds while maintaining them below their eutectic temperature such that water sublimes from the grape seeds; and extracting proanthocyanodins from the lyophilized grape seeds.
23. The method of claim 22, further comprising the step of pulverizing the grape seeds prior to freezing.
24. The method of claim 22, further comprising the step of pulverizing the grape seeds following drying and prior to extraction of the proanthocyanodins.
PCT/US1997/006821 1996-04-22 1997-04-22 Natural antioxidant composition Ceased WO1997039632A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU27411/97A AU2741197A (en) 1996-04-22 1997-04-22 Natural antioxidant composition
EP97921349A EP0897264A4 (en) 1996-04-22 1997-04-22 Natural antioxidant composition

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US1620896P 1996-04-22 1996-04-22
US60/016,208 1996-04-22
US82120197A 1997-03-20 1997-03-20
US08/821,201 1997-03-20

Publications (1)

Publication Number Publication Date
WO1997039632A1 true WO1997039632A1 (en) 1997-10-30

Family

ID=26688312

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1997/006821 Ceased WO1997039632A1 (en) 1996-04-22 1997-04-22 Natural antioxidant composition

Country Status (3)

Country Link
EP (1) EP0897264A4 (en)
AU (1) AU2741197A (en)
WO (1) WO1997039632A1 (en)

Cited By (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999025209A1 (en) * 1997-11-14 1999-05-27 Consejo Superior De Investigaciones Cientificas Concentrate of natural antioxidant dietetic fiber from grape, and preparation process
RU2133621C1 (en) * 1997-08-20 1999-07-27 Тихоокеанский институт биоорганической химии Дальневосточного отделения РАН Method of plant polyphenol extract preparing
WO2000078326A1 (en) * 1999-06-18 2000-12-28 Dry Creek Nutrition, Inc. Method and composition for preventing or treating adverse physiological effects associated with cardiac disease
US6291517B1 (en) 1999-11-19 2001-09-18 Dry Creek Nutrition, Inc Method for preventing or reducing stress-induced gastric injury using grape seed proanthocyanidin extract
EP1184453A1 (en) * 2000-08-31 2002-03-06 Stefanija Krug Preparation for dietary supplement and cosmetic purposes
RU2203077C2 (en) * 2000-02-14 2003-04-27 Сибирский государственный медицинский университет Method for producing means manifesting antioxidant activity
US6800433B1 (en) 1999-04-23 2004-10-05 Kyowa Hakko Kogyo Co., Ltd. Process for purification of proanthocyanidin oligomer
EP1047392A4 (en) * 1997-12-24 2004-10-06 Shaklee Corp Composition with high efficiency skin protection from damaging effects of ultraviolet light
ES2228284A1 (en) * 2003-03-24 2005-04-01 Agustin Soriano Casani Set of food products based on chaff extract consists of high antioxidant blends also containing black grape seeds and stalks
WO2005040835A3 (en) * 2003-10-22 2005-10-27 Michel Prost Method for determining the antiradical defense potential and use thereof, in particular in veterinary and human preventive therapeutics
US20060083796A1 (en) * 2002-09-09 2006-04-20 Sylvie Pridmore-Merten Orally administrable composition for improving hair and coat quality
ES2257196A1 (en) * 2004-10-29 2006-07-16 Consejo Superior Investig. Cientificas WINES OR VINIC PRODUCTS ENRIQUECIDOS IN POLYPHENOLIC COMPOUNDS AND ANTIOXIDANT CAPACITY.
US20060193945A1 (en) * 2005-06-17 2006-08-31 Nusci Laboratories Stabilization of oxidized fats
US7201931B2 (en) * 2001-08-07 2007-04-10 Indena S.P.A. Oral compositions for the treatment of scalp disorders
WO2008006923A1 (en) * 2006-07-14 2008-01-17 Universidad De Barcelona Method for preparing a condiment based on grape fermentation, condiment thus obtained and use thereof to inhibit the development of mutagens and/or carcinogens
EP1347769A4 (en) * 2000-12-05 2008-02-20 Tahitian Noni Int Inc Cancer preventative effect of morinda citrifolia
WO2009064765A1 (en) * 2007-11-15 2009-05-22 Monsanto Technology Llc Seed devitalization method
MD3979G2 (en) * 2008-09-30 2010-06-30 Институт Химии Академии Наук Молдовы Compound possessing antioxidant properties
US20110104328A1 (en) * 2008-01-08 2011-05-05 David Rubin Method and compositions for perserving wine
US20110111087A1 (en) * 2007-08-29 2011-05-12 Roberto Crea Food and beverage supplement
US8216599B2 (en) 2002-02-13 2012-07-10 Creagri, Inc. Method for treatment of inflammation
WO2013021076A1 (en) * 2011-08-10 2013-02-14 Abro Biotec, S.L. Grape extract, nutritional supplement comprising grape extract, and the use thereof as a functional ingredient
CN103099759A (en) * 2013-02-27 2013-05-15 蒋彩云 Extraction of active components from blackberry seeds, hawthorn seeds and pomegranate seeds and preparation of applying mask
US20140356288A1 (en) * 2013-05-29 2014-12-04 Melissa Kirkpatrick Topical Examination Compositions and Methods
EP2567734A3 (en) * 2011-09-06 2015-05-06 Stefanija Krug Substance for preparing a mouthwash
CN105669780A (en) * 2016-01-14 2016-06-15 张敬明 Method for raising polyphenol content and water-solubility of grape seed extract
US9789149B2 (en) 2005-07-19 2017-10-17 Creagri, Inc. Vegetation water composition for treatment of inflammatory skin conditions
KR20200000225A (en) * 2018-06-22 2020-01-02 한국화학연구원 Anti-bacterial composition comprising 3,4-di-caffeoylquinic acid or pharmaceutically acceptable salts thereof as an active ingradient
US20220154298A1 (en) * 2020-11-19 2022-05-19 Hyundai Motor Company Leather odor removal composition and method of manufacturing leather with reduced odor using the same
WO2023023309A1 (en) 2021-08-20 2023-02-23 Finless Foods Inc. Systems and methods for fish tissue preservation

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4698360A (en) * 1985-04-09 1987-10-06 Societe Civile D'investigations Pharmacologiques D'aquitaine Plant extract with a proanthocyanidins content as therapeutic agent having radical scavenger effect and use thereof
US4761285A (en) * 1986-10-28 1988-08-02 Athanasios Vasiliou Composition for relief and treatment of hemorrhoids
JPH04247022A (en) * 1991-01-31 1992-09-03 Kiyuubitsuku House:Kk Bath agent and its production
US5424084A (en) * 1991-05-02 1995-06-13 Nippi, Incorporated Process for preparing collagen beads

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4698360A (en) * 1985-04-09 1987-10-06 Societe Civile D'investigations Pharmacologiques D'aquitaine Plant extract with a proanthocyanidins content as therapeutic agent having radical scavenger effect and use thereof
US4698360B1 (en) * 1985-04-09 1997-11-04 D Investigations Pharmacologiq Plant extract with a proanthocyanidins content as therapeutic agent having radical scavenger effect and use thereof
US4761285A (en) * 1986-10-28 1988-08-02 Athanasios Vasiliou Composition for relief and treatment of hemorrhoids
JPH04247022A (en) * 1991-01-31 1992-09-03 Kiyuubitsuku House:Kk Bath agent and its production
US5424084A (en) * 1991-05-02 1995-06-13 Nippi, Incorporated Process for preparing collagen beads

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
FOOD SCIENCE, 1995, POTTER et al., CHAPMAN & HALL, pages 227-29. *
See also references of EP0897264A4 *
SINGLETON et al., "Phenol Substances in Grapes and Wine and Their Significance", ACADEMIC PRESS, 1969, pages 150-61. *
VITIS, 1979, 18(3), DARNE et al., "Method for Extraction of Total Soluble Lipids, Total, Soluble Carbohydrates and Total Soluble Phenolic Compounds in Vine Plant Parts", pages 221-28. *

Cited By (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2133621C1 (en) * 1997-08-20 1999-07-27 Тихоокеанский институт биоорганической химии Дальневосточного отделения РАН Method of plant polyphenol extract preparing
ES2130092A1 (en) * 1997-11-14 1999-06-16 Consejo Superior Investigacion Concentrate of natural antioxidant dietetic fiber from grape, and preparation process
WO1999025209A1 (en) * 1997-11-14 1999-05-27 Consejo Superior De Investigaciones Cientificas Concentrate of natural antioxidant dietetic fiber from grape, and preparation process
EP1047392A4 (en) * 1997-12-24 2004-10-06 Shaklee Corp Composition with high efficiency skin protection from damaging effects of ultraviolet light
US6800433B1 (en) 1999-04-23 2004-10-05 Kyowa Hakko Kogyo Co., Ltd. Process for purification of proanthocyanidin oligomer
WO2000078326A1 (en) * 1999-06-18 2000-12-28 Dry Creek Nutrition, Inc. Method and composition for preventing or treating adverse physiological effects associated with cardiac disease
US6495593B1 (en) 1999-06-18 2002-12-17 Dry Creek Nutrition, Inc. Compositions for preventing or treating adverse physiological effects associated with cardiac disease
US6291517B1 (en) 1999-11-19 2001-09-18 Dry Creek Nutrition, Inc Method for preventing or reducing stress-induced gastric injury using grape seed proanthocyanidin extract
RU2203077C2 (en) * 2000-02-14 2003-04-27 Сибирский государственный медицинский университет Method for producing means manifesting antioxidant activity
EP1184453A1 (en) * 2000-08-31 2002-03-06 Stefanija Krug Preparation for dietary supplement and cosmetic purposes
EP1347769A4 (en) * 2000-12-05 2008-02-20 Tahitian Noni Int Inc Cancer preventative effect of morinda citrifolia
US7201931B2 (en) * 2001-08-07 2007-04-10 Indena S.P.A. Oral compositions for the treatment of scalp disorders
US8216599B2 (en) 2002-02-13 2012-07-10 Creagri, Inc. Method for treatment of inflammation
US20060083796A1 (en) * 2002-09-09 2006-04-20 Sylvie Pridmore-Merten Orally administrable composition for improving hair and coat quality
ES2228284A1 (en) * 2003-03-24 2005-04-01 Agustin Soriano Casani Set of food products based on chaff extract consists of high antioxidant blends also containing black grape seeds and stalks
ES2228284B1 (en) * 2003-03-24 2006-07-16 Agustin Soriano Casani COMPOSITIONS THAT INCLUDE AN EXTRACT OF HOLLEJO, SEEDS AND SCRAPS OF BLACK GRAPE.
WO2005040835A3 (en) * 2003-10-22 2005-10-27 Michel Prost Method for determining the antiradical defense potential and use thereof, in particular in veterinary and human preventive therapeutics
ES2257196B1 (en) * 2004-10-29 2007-08-01 Consejo Superior Investig. Cientificas WINES OR VINIC PRODUCTS ENRIQUECIDOS IN POLYPHENOLIC COMPOUNDS AND ANTIOXIDANT CAPACITY.
ES2257196A1 (en) * 2004-10-29 2006-07-16 Consejo Superior Investig. Cientificas WINES OR VINIC PRODUCTS ENRIQUECIDOS IN POLYPHENOLIC COMPOUNDS AND ANTIOXIDANT CAPACITY.
US20060193945A1 (en) * 2005-06-17 2006-08-31 Nusci Laboratories Stabilization of oxidized fats
US9789149B2 (en) 2005-07-19 2017-10-17 Creagri, Inc. Vegetation water composition for treatment of inflammatory skin conditions
ES2299364A1 (en) * 2006-07-14 2008-05-16 Universidad De Barcelona Method for preparing a condiment based on grape fermentation, condiment thus obtained and use thereof to inhibit the development of mutagens and/or carcinogens
WO2008006923A1 (en) * 2006-07-14 2008-01-17 Universidad De Barcelona Method for preparing a condiment based on grape fermentation, condiment thus obtained and use thereof to inhibit the development of mutagens and/or carcinogens
ES2299364B1 (en) * 2006-07-14 2009-04-01 Universidad De Barcelona CONDIMENT AND ITS USE TO INHIBIT THE DEVELOPMENT OF MUTAGENS AND / OR CARCINOGENS.
US20110111087A1 (en) * 2007-08-29 2011-05-12 Roberto Crea Food and beverage supplement
WO2009064765A1 (en) * 2007-11-15 2009-05-22 Monsanto Technology Llc Seed devitalization method
US8871284B2 (en) * 2008-01-08 2014-10-28 Ysdr Llc Method and compositions for preserving wine
US20110104328A1 (en) * 2008-01-08 2011-05-05 David Rubin Method and compositions for perserving wine
US9752110B2 (en) 2008-01-08 2017-09-05 Ysdr, Llc Method and compositions of preserving wine
MD3979G2 (en) * 2008-09-30 2010-06-30 Институт Химии Академии Наук Молдовы Compound possessing antioxidant properties
WO2013021076A1 (en) * 2011-08-10 2013-02-14 Abro Biotec, S.L. Grape extract, nutritional supplement comprising grape extract, and the use thereof as a functional ingredient
EP2567734A3 (en) * 2011-09-06 2015-05-06 Stefanija Krug Substance for preparing a mouthwash
CN103099759A (en) * 2013-02-27 2013-05-15 蒋彩云 Extraction of active components from blackberry seeds, hawthorn seeds and pomegranate seeds and preparation of applying mask
US20140356288A1 (en) * 2013-05-29 2014-12-04 Melissa Kirkpatrick Topical Examination Compositions and Methods
CN105669780A (en) * 2016-01-14 2016-06-15 张敬明 Method for raising polyphenol content and water-solubility of grape seed extract
KR20200000225A (en) * 2018-06-22 2020-01-02 한국화학연구원 Anti-bacterial composition comprising 3,4-di-caffeoylquinic acid or pharmaceutically acceptable salts thereof as an active ingradient
KR102566556B1 (en) * 2018-06-22 2023-08-11 한국화학연구원 Anti-bacterial composition comprising 3,4-di-caffeoylquinic acid or pharmaceutically acceptable salts thereof as an active ingradient
US20220154298A1 (en) * 2020-11-19 2022-05-19 Hyundai Motor Company Leather odor removal composition and method of manufacturing leather with reduced odor using the same
US11981970B2 (en) * 2020-11-19 2024-05-14 Hyundai Motor Company Leather odor removal composition and method of manufacturing leather with reduced odor using the same
WO2023023309A1 (en) 2021-08-20 2023-02-23 Finless Foods Inc. Systems and methods for fish tissue preservation

Also Published As

Publication number Publication date
EP0897264A1 (en) 1999-02-24
AU2741197A (en) 1997-11-12
EP0897264A4 (en) 1999-09-08

Similar Documents

Publication Publication Date Title
WO1997039632A1 (en) Natural antioxidant composition
EP1667699B1 (en) Compositions comprising lotus extracts and methyl donors
JP2003306446A (en) Skin aging inhibitor and / or acne improving agent kit
KR20190099356A (en) Avocado flesh and/or skin extract rich in polyphenols and cosmetic, dermatological and nutraceutical compositions comprising same
KR20130083773A (en) Composition for improving skin wrinkle and enhancing elasticity
KR101652584B1 (en) Composition for Preventing Hair Loss or Improving Hair Growth
CN100436442C (en) Methods of producing flavonoid-containing compositions and their use
JP2005029486A (en) Skin-improving composition
JPH115975A (en) Active oxygen scavenger and use thereof
JP2000044485A (en) Active oxygen species scavenger and skin cosmetic
KR100888753B1 (en) Composition comprising an extract of Cornus kousa or the compounds isolated therefrom having anti-aging and anti-wrinkle activity
KR100953278B1 (en) Cosmetic composition for anti-inflammatory and skin irritation
KR20190137328A (en) Skin external application composition for anti-aging containing Rhodotypos scandens extract
JP2012111727A (en) Cell activator
WO2015015816A1 (en) Fibroblast activator
JP3742084B2 (en) Mannentake extract by specific extraction method and production method thereof
US8445028B2 (en) Echinoderm-derived extracts, methods of preparation and uses thereof
JP6902329B2 (en) Inhibitor of sebaceous gland cell activation
KR100939658B1 (en) Black Garlic, Overweight, Total White Blend Extract
JP2001151788A (en) Method for culturing marine microalga, hyaluronidase inhibitor, medicinal agent, cosmetic and food comprising its extract as active ingredient
JP3226359B2 (en) Lipid peroxide production inhibitor and composition containing the same
JPH0820544A (en) Reactive oxygen eliminator and food products and cosmetics formulated therewith
JP2024502775A (en) Composition for skin improvement
WO2015015815A1 (en) Fibroblast activator
JP2007031287A (en) Cosmetics

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 1997921349

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1997921349

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

NENP Non-entry into the national phase

Ref country code: JP

Ref document number: 97538311

Format of ref document f/p: F

NENP Non-entry into the national phase

Ref country code: CA

WWW Wipo information: withdrawn in national office

Ref document number: 1997921349

Country of ref document: EP